Top

Published in:

01-02-2014 | Prostate Cancer (D Parekh, Section Editor)

Prevention and Treatment of Biopsy-Related Complications

Authors: Ramgopal Satyanarayana, Dipen Parekh

Published in: Current Urology Reports | Issue 2/2014

Abstract

Transrectal biopsy of the prostate is necessary in the diagnosis of prostate cancer (PC). Though generally considered safe, patients encounter minor complications such as bleeding and urinary symptoms, and uncommonly, serious infections that may require antibiotic therapy, visits to the emergency room (ER) or hospital admission, causing morbidity and rarely even mortality. It is concerning that infections are on the rise due to resistant bacteria. Urologists will have to be aware of bacterial susceptibility studies to reduce such complications. This review focuses on prostate biopsy and its complications, and measures to reduce these complications in our practice.

Sieber PR et al. Antibiotic prophylaxis in ultrasound guided transrectal prostate biopsy. J Urol. 1997;157(6):2199–200.PubMedCrossRef

Levine MA et al. Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer. J Urol. 1998;159(2):471–5. discussion 475–6.PubMedCrossRef

Enlund AL, Varenhorst E. Morbidity of ultrasound-guided transrectal core biopsy of the prostate without prophylactic antibiotic therapy. A prospective study in 415 cases. Br J Urol. 1997;79(5):777–80.PubMedCrossRef

4.•

Pinkhasov GI et al. Complications following prostate needle biopsy requiring hospital admission or emergency department visits - experience from 1000 consecutive cases. BJU Int. 2012;110(3):369–74. This article focuses on a single center experience of over 1,000 biopsies, with emphasis on reasons for admission and ER visits.PubMedCrossRef

Puig J et al. Transrectal ultrasound-guided prostate biopsy: is antibiotic prophylaxis necessary? Eur Radiol. 2006;16(4):939–43.PubMedCrossRef

6.•

Loeb S et al. Complications after prostate biopsy: data from SEER-Medicare. J Urol. 2011;186(5):1830–4. This article concludes that serious infections are on the rise and serious non-infections are stable.PubMedCrossRef

Carmignani L et al. Bacterial sepsis following prostatic biopsy. Int Urol Nephrol. 2012;44(4):1055–63.PubMedCrossRef

Carter HB et al. Early detection of prostate cancer: AUA Guideline. J Urol. 2013;190(2):419–26.PubMedCrossRef

Koc G et al. Does washing the biopsy needle with povidone-iodine have an effect on infection rates after transrectal prostate needle biopsy? Urol Int. 2010;85(2):147–51.PubMedCrossRef

10.

Toren P, Razik R, Trachtenberg J. Catastrophic sepsis and hemorrhage following transrectal ultrasound guided prostate biopsies. Can Urol Assoc J. 2010;4(1):E12–4.PubMedCentralPubMed

11.

Raaijmakers R et al. Complication rates and risk factors of 5802 transrectal ultrasound-guided sextant biopsies of the prostate within a population-based screening program. Urology. 2002;60(5):826–30.PubMedCrossRef

12.

Zaytoun OM et al. Morbidity of prostate biopsy after simplified versus complex preparation protocols: assessment of risk factors. Urology. 2011;77(4):910–4.PubMedCrossRef

13.

Ghani KR, Dundas D, Patel U. Bleeding after transrectal ultrasonography-guided prostate biopsy: a study of 7-day morbidity after a six-, eight- and 12-core biopsy protocol. BJU Int. 2004;94(7):1014–20.PubMedCrossRef

14.

Chowdhury R et al. Should warfarin or aspirin be stopped prior to prostate biopsy? An analysis of bleeding complications related to increasing sample number regimes. Clin Radiol. 2012;67(12):e64–70.PubMedCrossRef

15.

Cicione A et al. Prostate biopsy quality is independent of needle size: a randomized single-center prospective study. Urol Int. 2012;89(1):57–60.PubMedCrossRef

16.

Rosario DJ et al. Short term outcomes of prostate biopsy in men tested for cancer by prostate specific antigen: prospective evaluation within ProtecT study. BMJ. 2012;344:d7894.PubMedCentralPubMedCrossRef

17.

Petroski RA, Griewe GL, Schenkman NS. Delayed life-threatening hemorrhage after transrectal prostate needle biopsy. Prostate Cancer Prostatic Dis. 2003;6(2):190–2.PubMedCrossRef

18.

Katsinelos P et al. Endoclipping treatment of life-threatening rectal bleeding after prostate biopsy. World J Gastroenterol. 2009;15(9):1130–3.PubMedCrossRef

19.

Manoharan M et al. Hemospermia following transrectal ultrasound-guided prostate biopsy: a prospective study. Prostate Cancer Prostatic Dis. 2007;10(3):283–7.PubMedCrossRef

20.

Berger AP et al. Complication rate of transrectal ultrasound guided prostate biopsy: a comparison among 3 protocols with 6, 10 and 15 cores. J Urol. 2004;171(4):1478–80. discussion 1480–1.PubMedCrossRef

21.

Abdelkhalek M et al. Hemosepermia after transrectal ultrasound-guided prostatic biopsy: a prospective study. Urol Ann. 2013;5(1):30–3.PubMedCentralPubMedCrossRef

22.

Brullet E et al. Massive rectal bleeding following transrectal ultrasound-guided prostate biopsy. Endoscopy. 2000;32(10):792–5.PubMedCrossRef

23.

Kilciler M et al. The effect of rectal Foley catheterization on rectal bleeding rates after transrectal ultrasound-guided prostate biopsy. J Vasc Interv Radiol. 2008;19(9):1344–6.PubMedCrossRef

24.

Pacios E et al. Endoscopic treatment of massive rectal bleeding following transrectal ultrasound-guided prostate biopsy. Scand J Urol Nephrol. 2007;41(6):561–2.PubMedCrossRef

25.

Siegelbaum MH et al. Congenital pelvic arteriovenous malformation with massive prostatic hemorrhage: a case report. J Urol. 1989;141(2):382–4.PubMed

26.

Kaneko T et al. Transcatheter arterial embolization for bleeding of prostatic artery after prostate biopsy. Nihon Hinyokika Gakkai Zasshi. 2003;94(7):693–5.PubMed

27.

Abd-Alazeez M, et al. The accuracy of multiparametric MRI in men with negative biopsy and elevated PSA level-Can it rule out clinically significant prostate cancer? Urol Oncol. 2013.

28.

Rodriguez LV, Terris MK. Risks and complications of transrectal ultrasound guided prostate needle biopsy: a prospective study and review of the literature. J Urol. 1998;160(6 Pt 1):2115–20.PubMed

29.•

Carmignani L et al. Transrectal ultrasound-guided prostate biopsies in patients taking aspirin for cardiovascular disease: a meta-analysis. Transfus Apher Sci. 2011;45(3):275–80. This article concludes that stopping aspirin routinely is not necessary, because it does not increase the risk of moderate or severe bleeding after prostate biopsy.PubMedCrossRef

30.

Armstrong MJ et al. Summary of evidence-based guideline: periprocedural management of antithrombotic medications in patients with ischemic cerebrovascular disease: report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2013;80(22):2065–9.PubMedCrossRef

31.

Brewster SF et al. Fatal anaerobic infection following transrectal biopsy of a rare prostatic tumour. Br J Urol. 1993;72(6):977–8.PubMedCrossRef

32.

Brown RW et al. Bacteremia and bacteriuria after transrectal prostatic biopsy. Urology. 1981;18(2):145–8.PubMedCrossRef

33.

Nam RK et al. Increasing hospital admission rates for urological complications after transrectal ultrasound guided prostate biopsy. J Urol. 2013;189(1 Suppl):S12–7. discussion S17-8.PubMedCrossRef

34.

Al-Hasan MN et al. Antimicrobial resistance trends of Escherichia coli bloodstream isolates: a population-based study, 1998–2007. J Antimicrob Chemother. 2009;64(1):169–74.PubMedCrossRef

35.

Chen YH et al. Antimicrobial susceptibility profiles of aerobic and facultative Gram-negative bacilli isolated from patients with intra-abdominal infections in the Asia-Pacific region according to currently established susceptibility interpretive criteria. J Infect. 2011;62(4):280–91.PubMedCrossRef

36.

Batura D et al. Adding amikacin to fluoroquinolone-based antimicrobial prophylaxis reduces prostate biopsy infection rates. BJU Int. 2011;107(5):760–4.PubMedCrossRef

37.

Abughosh Z et al. A prospective randomized trial of povidone-iodine prophylactic cleansing of the rectum before transrectal ultrasound guided prostate biopsy. J Urol. 2013;189(4):1326–31.PubMedCrossRef

38.

Ghafoori M et al. Decrease in infection rate following use of povidone-iodine during transrectal ultrasound guided biopsy of the prostate: a double blind randomized clinical trial. Iran J Radiol. 2012;9(2):67–70.PubMedCentralPubMedCrossRef

39.

Zani EL, Clark OA, Rodrigues Netto Jr N. Antibiotic prophylaxis for transrectal prostate biopsy. Cochrane Database Syst Rev. 2011;5, CD006576.PubMed

40.

Vallancien G et al. Systematic prostatic biopsies in 100 men with no suspicion of cancer on digital rectal examination. J Urol. 1991;146(5):1308–12.PubMed

41.

Carey JM, Korman HJ. Transrectal ultrasound guided biopsy of the prostate. Do enemas decrease clinically significant complications? J Urol. 2001;166(1):82–5.PubMedCrossRef

42.

Jeon SS et al. Bisacodyl rectal preparation can decrease infectious complications of transrectal ultrasound-guided prostate biopsy. Urology. 2003;62(3):461–6.PubMedCrossRef

43.

Adibi M et al. Reduction in hospital admission rates due to post-prostate biopsy infections after augmenting standard antibiotic prophylaxis. J Urol. 2013;189(2):535–40.PubMedCrossRef

44.

Horcajada JP et al. High prevalence of extended-spectrum beta-lactamase-producing enterobacteriaceae in bacteremia after transrectal ultrasound-guided prostate biopsy: a need for changing preventive protocol. Urology. 2009;74(6):1195–9.PubMedCrossRef

45.

Gan VH et al. Does periprostatic block increase the transrectal ultrasound (TRUS) biopsy sepsis rate in men with elevated PSA? Ann Acad Med Singap. 2013;42(4):168–72.PubMed

46.

Pace G et al. Cephalosporins periprostatic injection: are really effective on infections following prostate biopsy? Int Urol Nephrol. 2012;44(4):1065–70.PubMedCrossRef

47.

Taylor S et al. Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy. BJU Int. 2013;111(6):946–53.PubMedCrossRef

48.

Liss MA et al. Prevalence and significance of fluoroquinolone resistant Escherichia coli in patients undergoing transrectal ultrasound guided prostate needle biopsy. J Urol. 2011;185(4):1283–8.PubMedCrossRef

49.

Steensels D et al. Fluoroquinolone-resistant E. coli in intestinal flora of patients undergoing transrectal ultrasound-guided prostate biopsy–should we reassess our practices for antibiotic prophylaxis? Clin Microbiol Infect. 2012;18(6):575–81.PubMedCrossRef

50.

Duplessis CA et al. Rectal cultures before transrectal ultrasound-guided prostate biopsy reduce post-prostatic biopsy infection rates. Urology. 2012;79(3):556–61.PubMedCrossRef

51.•

Patel U et al. Infection after transrectal ultrasonography-guided prostate biopsy: increased relative risks after recent international travel or antibiotic use. BJU Int. 2012;109(12):1781–5. Very interesting article that focuses on bowel flora alterations after international travel and possible higher infections.PubMedCrossRef

52.

Kennedy K, Collignon P. Colonisation with Escherichia coli resistant to "critically important" antibiotics: a high risk for international travellers. Eur J Clin Microbiol Infect Dis. 2010;29(12):1501–6.PubMedCrossRef

53.

Suzuki M et al. Safety of transperineal 14-core systematic prostate biopsy in diabetic men. Int J Urol. 2009;16(12):930–5.PubMedCrossRef

54.

Shen PF et al. The results of transperineal versus transrectal prostate biopsy: a systematic review and meta-analysis. Asian J Androl. 2012;14(2):310–5.PubMedCrossRef

55.

Issa MM, et al. Formalin Disinfection of Biopsy Needle Minimizes the Risk of Sepsis Following Prostate Biopsy. J Urol. 2013.

56.

Tuncel A et al. Does disposable needle guide minimize infectious complications after transrectal prostate needle biopsy? Urology. 2008;71(6):1024–7. discussion 1027–8.PubMedCrossRef

57.

Loeb S et al. Is repeat prostate biopsy associated with a greater risk of hospitalization? Data from SEER-Medicare. J Urol. 2013;189(3):867–70.PubMedCrossRef

58.

Fujita K et al. Serial prostate biopsies are associated with an increased risk of erectile dysfunction in men with prostate cancer on active surveillance. J Urol. 2009;182(6):2664–9.PubMedCrossRef

59.

Hilton JF et al. The impact of serial prostate biopsies on sexual function in men on active surveillance for prostate cancer. J Urol. 2012;188(4):1252–8.PubMedCrossRef

60.

Akyol I, Adayener C. Transient impotence after transrectal ultrasound-guided prostate biopsy. J Clin Ultrasound. 2008;36(1):33–4.PubMedCrossRef

61.

Akbal C et al. Erectile function in prostate cancer-free patients who underwent prostate saturation biopsy. Eur Urol. 2008;53(3):540–4.PubMedCrossRef

62.

Zisman A et al. The impact of prostate biopsy on patient well-being: a prospective study of voiding impairment. J Urol. 2001;166(6):2242–6.PubMedCrossRef

63.

Bozlu M et al. Voiding impairment after prostate biopsy: does tamsulosin treatment before biopsy decrease this morbidity? Urology. 2003;62(6):1050–3.PubMedCrossRef

64.

Pinsky PF, Parnes HL, Andriole G. Mortality and Complications Following Prostate Biopsy in the PLCO Cancer Screening Trial. BJU Int. 2013.

65.••

Loeb S, et al. Systematic review of complications of prostate biopsy. Eur Urol, 2013. This is a comprehensive review of post biopsy complications.

66.

Loeb S et al. Infectious complications and hospital admissions after prostate biopsy in a European randomized trial. Eur Urol. 2012;61(6):1110–4.PubMedCrossRef

Title: Prevention and Treatment of Biopsy-Related Complications
Authors: Ramgopal Satyanarayana
Dipen Parekh
Publication date: 01-02-2014
Publisher: Springer US
Published in: Current Urology Reports / Issue 2/2014
Print ISSN: 1527-2737
Electronic ISSN: 1534-6285
DOI: https://doi.org/10.1007/s11934-013-0381-2

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Prevention and Treatment of Biopsy-Related Complications

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2014

Implications of the FDA Statement on Transvaginal Placement of Mesh: The Aftermath

Repair of Pelvic Organ Prolapse: What is the Goal?

Affordable Care Act: Implications in Female Pelvic Medicine and Reconstructive Surgery

Trends in Surgical Management of T1 Renal Cell Carcinoma

Painful Bladder Syndrome: An Update and Review of Current Management Strategies